Chugai Pharmaceutical reports 1H results (CHGCF:OTCMKTS)
Empty output
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Empty output
Chugai Pharmaceutical reports 1H results (CHGCF:OTCMKTS) | Seeking Alpha
Save
Play
(
<1min
)
Comments
Chugai Pharmaceutical
press release
(
CHGCF
): 1H EPS: ¥140.82, ¥144.84
Revenue: ¥663,300M
Product sales: ¥566,500M
Other revenue: ¥96,800M
Operating profit: ¥319,600M , ¥329,100M
Cost of sales: ¥197,000M
Research & development expenses: ¥89,600M
Selling, general and administrative expenses: ¥57,900M
Other operating income (expenses): ¥900M
Financial income/expenses: ¥9,600M
More on Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation
Historical earnings data for Chugai Pharmaceutical Co., Ltd.
Financial information for Chugai Pharmaceutical Co., Ltd.
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Solana Company Stakes 500K SOL on Tokyo Cluster, Validator Rewards Expected by Q3 2026
A Solana infrastructure firm has pledged 500,000 SOL to support its Tokyo cluster, with first validator rewards projected for Q3 2026, signaling confidence in network decentralization and Asian expansion.
Barfresh outlines $23M-$26M FY2026 revenue outlook while targeting partial commissioning of Defiance plant by end of 2026 (NASDAQ:BRFH)
Barfresh (BRFH) Q2 2026 earnings call recap: Arps-driven revenue growth, production ramp issues, and revised FY2026 guidance.
Sidus Fortis VPX Commercial Launch in 2027 Backed by $158.5M Funding
Sidus Space announces the commercial availability of its Fortis VPX edge computing module by early 2027, supported by $158.5M raised in Q2 2025. Learn about its technology advantages, market outlook, and financial health.
TOMI Reaffirms 2026 Revenue Guidance of at Least $12M, Sets $10M Funding Goal for Carbonium Core Merger
TOMI Environmental Solutions reaffirms its 2026 revenue guidance of at least $12 million and advances its merger with Carbonium Core, targeting $10 million in funding. This article analyzes the strategic implications, industry context, and potential risks.
